<DOC>
	<DOCNO>NCT00185367</DOCNO>
	<brief_summary>The aim study evaluate bleeding pattern , cycle control , safety new four-phasic oral contraceptive comparison reference OC .</brief_summary>
	<brief_title>Comparative Cycle Control Europe</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany.Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<criteria>Healthy female volunteer age 18 50 year require contraception Pregnancy lactation Any condition might interfere outcome well contraindication OC use</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>